Ben Rundle (BUY): I agree with Martin. I think it’s a buy for all the reasons he mentioned. I think the strong conditions they’re seeing at the moment will persist for a while, and management’s done a fantastic job with this company. They’ve grown the earnings three times since they listed, and they haven’t required extra capital to do so. So, when they say they’ve got new initiatives that they’ve been working on for a while, I’m happy to back them.
Capitol Health (ASX: CAJ)
Ally Selby: Next up, we have diagnostic imaging business, Capitol Health, which recently announced a dividend of 0.5 cents per share. It has an annual yield of around 3 per cent. Staying with you, Ben, is it a buy, hold, or sell?
Ben Rundle (HOLD): I think Capital Health’s a hold. I think that management has done a really good job turning the ship around, here. My concern is, though, in an inflationary environment, you’re relying on the government to come to the party with their indexation, and make sure that keeps up with CPI. And I really can’t see that happening, so it’s a hold for now.
Ally Selby: Its share price has fallen around 13 per cent since the beginning of the year. Is it a buy, hold, or sell?
Martin Hickson (BUY): We think it’s a buy. The new CEO, Justin Walter, has done a fantastic job turning the ship around, as Ben mentioned. They’ve got $100 million in firepower to deploy into acquisitions, trades on an EV/EBITDA multiple of eight times, versus private transactions being done at 12 times. So, we think it’s a buy.
Ally Selby: Let’s talk Brickworks. It has an annual dividend yield of around 2.8 per cent, and announced a dividend of 40 cents per share. Is it a buy, hold, or sell?
Martin Hickson (BUY): It’s one for those investors that do like a dividend yield. The company’s paid a dividend for 30 years without stopping, and that’s as far back as my data goes. It’s also very cheap, it’s on a PE of less than 10 times. Growing here in Australia, based on the construction and renovation boom, also has a growing North American business. So, we think it’s a buy.
Ally Selby: Its share price has dropped nearly 13 per cent in 2022. Is it a buy, hold, or sell?
Ben Rundle (BUY): I agree. I think it’s a buy. I think you’ve got a first-class management team. Our sum of the parts valuation is somewhere closer to $26, buying it $21 at the moment. They report in a week’s time, and they’ve already said pre-Christmas that conditions were very strong. I think it’s a buy.
Ally Selby: Next up, we have McPherson’s, which has an annual yield of around 5.8 per cent and announced a dividend of three cents per share in February. Is it a buy, hold, or sell?
Ben Rundle (SELL): I think McPherson’s is a sell. This is a business with an abysmal track record. Over the last 10 years, they’ve doubled the capital contribution to the business and significantly diluted the equity for no earnings growth at all. I think they come up with a new product every few years. It never endures. It’s a sell.
Ally Selby: Well, they actually recently appointed a new chair. His name is Ari Mervis. He used to be a beer and dairy executive. Do you think he could turn the business around? Is it a buy, hold, or sell?
Martin Hickson (SELL): Unfortunately, I agree with Ben. I think it’s a sell. It screams cheap. It’s got a yield, but I think it’s a value trap. They’ve had a lot of problems with a lot of their new products, Multix, doesn’t have a lot of pricing power. We think it’s a sell, as well.
Ally Selby: Last, but certainly not least, we have Money3, which has an annual yield of around 4.4 per cent and announced a dividend of six cents in February. Is it a buy, hold, or sell?
Martin Hickson (BUY): We think it’s a buy. They’ve just reported a very strong result in February, first-half earnings up 30 per cent. We think the guidance of greater than $50 million profit is conservative. So, we think Money3 is a buy.
Ally Selby: Its share price is down 17 per cent in 2022. Should investors be picking this up?
Ben Rundle (BUY): Yep! I agree with Martin. I think it’s a buy. As he pointed out, they upgraded earnings the other day and they probably will upgrade again. They’ve just got more funding as well, which can support their growth plans. So, I think it’s a buy.
Ally Selby: Well, there were plenty of buys in there for you, today. We hope you enjoyed that episode of Buy, Hold, Sell. If you did, why not give it a like? Remember to subscribe to our YouTube channel. We’re adding new content every week.
Buy Hold Sell is a weekly video series produced by Livewire Markets.
Disclaimer: The information contained in this presentation is general in nature and should not be relied upon. Before making any investment of financial planning decisions, you should consult a licensed professional who can advise you whether the decision is appropriate for you. Contributors to this show may have commercial or financial interests in the companies mentioned